Our team has a dream: to reinvent the way we observe and treat the human brain. Neuroelectrics has created diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. We aim to help patients recover their brain health in pathologies such as chronic pain and stroke rehabilitation. You can find us in our offices in Boston (MA-US) and Barcelona (Spain).
Ana Maiques is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain; developing innovative technologies to monitor and stimulate the brain. She was nominated by IESE as one of the most influential entrepreneurs under 40 in Spain in 2010, she was the only woman on that list. She received the EU Prize for Women Innovators from the European Commission EC in 2014. Also in 2014, she was an award recipient of the International Women’s Entrepreneurial Challenge. In 2015 & 2016, she was named one of most inspiring women on the Inspiring Fifty list in Europe of women technological leaders and innovators. As a company, Neuroelectrics received the Best Start-up in Health Award in 2015 by Wired UK magazine and in 2016 was recognized as one of the “Best Entrepreneurial Companies in America” by Entrepreneur Magazine’s Entrepreneur 360™ List, the most comprehensive analysis of private companies in America. Ana continues to break the barriers for women and entrepreneurs bringing together science and technology in an impactful way.
Dr. Giulio Ruffini obtained a BA in math and physics from Berkeley and a PhD in theoretical physics from UC Davis/LANL in 1995. In 2000 he and others founded Starlab to transform science into technologies with impact. He has provided the science and technology visions for Neuroelectrics, and believes that neuromodulation will make great advances thanks to the union of precision multifocal stimulation technologies with advanced biophysical and neuro-computational models, EEG and fMRI. His recent paper on brain-to-brain communication was the 9th most shared paper of 2014.
Paul graduated with a BS in Electrical Engineering from Carnegie-Mellon University in Pittsburgh PA, and an MBA from the Institute for Management Development (IMD) in Lausanne, Switzerland. Paul has been a founder and executive in several life sciences start-up companies, including Aleva Neurotherapeutics, a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL) developing advanced deep-brain stimulation systems for treatment of Parkinson’s disease and other movement disorders, and NetBio (Waltham, MA), a spin-off from the Whitehead Institute at MIT developing rapid DNA analysis systems for defense, security, and infectious disease diagnostics. Prior to this, Paul was an executive officer with the electronics technology company Ansoft Corporation (NASDAQ:ANST, acquired by ANSYS) where, among other roles, he set-up and managed all Japanese and Asian operations.
Patricia graduated in Chemistry Engineering from University of Barcelona, focussing on industrial processes and science. She has worked intensively in multinationals developing and improving Quality Management Systems and Regulatory affairs processes, acquiring extensive experience in the chemical and medical sectors. She has deep knowledge of European medical device regulations such as MDD 93/42/EEC, American (FDA), Canadian Health and Korean (KFDA) and the performance of the normative documents for CE marking, FDA 510(k), applications of the rules ISO 13485 - ISO 14971 - IEC / ISO 62304 – IEC 62366 - IEC 60601
Born in Spain in 1961, MD and PhD degrees in Neurophysiology from the Albert Ludwigs University in Germany. He also trained at he University of Minnesota and the US National Institutes of Health. Currently he is the Principal Investigator of the Center for Non-Invasive Brain Stimulation and Professor of Neurology at Harvard Medical School and the Beth Israel Deaconess Medical Center (Boston, USA). He is a world leader in the development of brain stimulation technologies (TMS and tDCS).
Prof. Laureys graduated as a Medical Doctor from the Vrije Universiteit Brussel, Belgium, in 1993. He obtained his Ph.D. studying residual brain function from the University of Liège. He currently leads the Coma Science Group at the Cyclotron Research Centre of the University of Liège. Laureys is chair of the World Federation of Neurology's Coma and Disorders of Consciousness Research Group and of the European Neurological Society's Subcommittee on Coma and Disorders of Consciousness. He is recognized worldwide as a leading clinician and researcher in the field of neurology of consciousness.
Dr. Adam Gazzaley obtained an M.D. and a Ph.D. in Neuroscience at the Mount Sinai School of Medicine in New York, completed clinical residency in Neurology at the University of Pennsylvania, and postdoctoral training in cognitive neuroscience at UC Berkeley. He is the founding director of the Neuroscience Imaging Center at the UC San Francisco, an Associate Professor in Neurology, Physiology and Psychiatry, and Principal Investigator of a cognitive neuroscience laboratory.
Wellcome RCD Fellow and University Research Lecturer at the University of Oxford, Prof. Kadosh is a leader in the study of the neuropsychological mechanisms of numerical and magnitude processing using advanced techniques such as tCS/tES. His main research focuses on the psychological and biological factors that shape learning and cognitive achievements. Understanding and enhancing learning and cognition have significant implications to different fields including psychology, neuroscience, education, and medicine, and have a translational impact for cognitive enhancement for clinical and non-clinical populations.
Currently, he is a Professor for Clinical Neurophysiology in the University of Göttingen (Germany). He is a tDCS pioneer and a key opinion leader in the field of non-invasive brain stimulation, neuroplasticity and neuropsychopharmacology, among others.
Niels Birbaumer is one of the leading figures in the history of brain-computer interfaces (BCI), which are direct communication devices between the brain and a computer. Birbaumer has been dealing with BCIs for as much as forty years. He believes in the power of BCIs, a power that is based on human imagination and is used to treat brain disturbances. The director of the Institute of Medical Psychology and Behavioural Neurology in Tübingen was awarded the prestigious Leibniz Prize in 1995 for his pioneering work on BCIs.
Emiliano has obtained a Ph.D., Applied Neurological Sciences from the University of Siena and a M.Sc., Cognitive Science, University of Florence, Italy. He currently splits his time as an Instructor in Neurology at Harvard Medical School and a clinical research scientist at the Berenson-Allen Center for Non-invasive Brain Stimulation. His research focuses on the combination of Non-Invasive Brain Stimulation (TMS, tCS), electrophysiology (e.g. EEG, MEG) and neuroimaging (e.g. fMRI) to develop methods for targeted manipulation of brain connectivity patterns which might translate into therapeutic options for neurological and psychiatric patients.
Pedro Cavaleiro Miranda obtained a BSc and a PhD in Physics from the University of Sussex, UK and an MSc in Computer Science from UCL, UK. He is currently an Associate Professor in the Faculty of Science of the University of Lisbon, where he teaches Biomedical Engineering, and a researcher at the Institute of Biophysics and Biomedical Engineering, in the same University. His expertise lies in the calculation of the electric field induced by non-invasive brain stimulation techniques, based on realistic models of the human head.
Prof. Wendling got his Engineer Diploma from the Technological University of Compiegne (France), his Master’s degree in bio-engineering from Georgia Tech (USA) and a PhD in signal processing from the University of Rennes (France). He has been working in the field of Biomedical Engineering applied to brain signals for 20 years developing advanced diagnostic methods based on nonlinear dynamics and electrophysiological signal processing. He has developed large-scale (EEG) models to explain tCS effects of on brain activity (FP7, FET-Open project Hive, 2008-12), in the context of epilepsy and consciousness (H2020, FET-Open project Luminous, 2014-20). He is now promoting the combination of computational, clinical and experimental approaches which could significantly improve our understanding of the mechanisms underlying various neurological disorders and lead to novel therapeutic procedures, in particular based on electrical stimulation.
Starlab Neuroscience is our R&D partner, including development of advanced products and data analytics services. Starlab Neuroscience aims to be a world leader in applied neuroscience. Through fundamental science, applied research, and consulting services, they explore the potential of new methodological approaches, technologies and techniques for real world impact of neurotechnologies. New product concepts and prototypes generated at Starlab Neuroscience are being transferred to Neuroelectrics for commercial uptake, while their consulting services are being offered directly to clients.
Cambridge, MA, USASee more
In two recent global market reports, QY Research and HTF Market Intelligence recognized Neuroelectrics as a key player in both the Electroencephalogram System (EEG) and electrode markets, respectively. While both reports involve different markets, it is clear that Neuroelectrics is making its mark in the global market as a leading organization in brain health.See more